Research Topics
Species | P MaisonneuveSummaryAffiliation: European Institute of Oncology Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Cancer in patients on dialysis for end-stage renal disease: an international collaborative studyP Maisonneuve
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Lancet 354:93-9. 1999..The aim of this study was to examine the risk of cancer in a large cohort of patients treated by dialysis but not transplantation...
Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative studyP Maisonneuve
Division of Epidemiology, European Institute of Oncology, Milan, Italy
Am J Kidney Dis 35:157-65. 2000....
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedureE Montagna
Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 118:385-94. 2009..Treatment recommendations for systemic therapy should not take into account the presence of a single micrometastatic lymph node identified during complete serial sectioning of sentinel node(s)...
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative diseaseM Colleoni
Research Unit in Medical Senology, Department of Medicine, Instituto Europeo di Oncologia, Milan, Italy
Ann Oncol 17:1497-503. 2006..There is limited knowledge about prognosis, and treatment effects in young women with node-negative disease...
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)C Bosetti
Department of Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Ann Oncol 23:1880-8. 2012..To evaluate the dose-response relationship between cigarette smoking and pancreatic cancer and to examine the effects of temporal variables...
Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinomaG Viale
Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan School of Medicine, Milan, Italy
Cancer 92:1378-84. 2001....
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancerG Cancello
Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy
Ann Oncol 21:1974-81. 2010..There is limited knowledge about prognosis of selected breast cancer subtypes among very young women...
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerM Colleoni
Research Unit in Medical Senology at the Department of Medicine, Istituto Europeo di Oncologia, Milan, Italy
Ann Oncol 18:1632-40. 2007..4%), focal (368, 14.1%), moderate (51, 2.0%) and extensive (170, 6.5%)...
Outcome of special types of luminal breast cancerM Colleoni
Department of Medicine, European Institute of Oncology, Milan, Italy
Ann Oncol 23:1428-36. 2012..The identification of special types of breast cancer might be of value in assessing prognosis and predicting response to therapy...
Carcinoma of the ovaryA P Heintz
FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Int J Gynaecol Obstet 83:135-66. 2003
Carcinoma of the Fallopian tubeA P Heintz
FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Int J Gynaecol Obstet 83:119-33. 2003
Carcinoma of the corpus uteriW T Creasman
FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Int J Gynaecol Obstet 83:79-118. 2003
Carcinoma of the cervix uteriJ L Benedet
FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Int J Gynaecol Obstet 83:41-78. 2003
Carcinoma of the vaginaU Beller
FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Int J Gynaecol Obstet 83:27-39. 2003
Gestational trophoblastic diseasesH Y Ngan
FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Int J Gynaecol Obstet 83:167-74. 2003
Nipple sparing mastectomy: can we predict the factors predisposing to necrosis?Z K Algaithy
Division of Plastic Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Eur J Surg Oncol 38:125-9. 2012..This study aimed to analyze the factors that may lead to skin necrosis after NSM...
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypesG Cancello
Unit of Research in Medical Senology, Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast Cancer Res Treat 127:713-20. 2011..In conclusion, women with small size, node-negative, breast cancer are at higher risk of relapse if with HER2-positive endocrine receptor absent or Triple Negative disease...
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)E Lucenteforte
Department of Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri Milan, Milan, Italy
Ann Oncol 23:374-82. 2012..Heavy alcohol drinking has been related to pancreatic cancer, but the issue is still unsolved...
Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysisS Iodice
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Eur J Cancer 46:2275-84. 2010..The association between oral contraceptive and BRCA1 or BRCA2 gene mutations carriers is unclear...
Timing of breast cancer surgery in relation to the menstrual cycle: an update of developmentsS Zurrida
Senology Department, European Institute of Oncology, Milan, Italy
Crit Rev Oncol Hematol 38:223-30. 2001..It is too early to assess the significance of this finding...
Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodesM Manzotti
Department of Pathology, European Institute of Oncology, Via Ripmaonti 435, I-20141 Milan, Italy
Int J Cancer 95:307-12. 2001..4% and 84.6%, respectively). The high prevalence of positive reverse transcription-polymerase chain reaction assays in histologically uninvolved SLNs, however, may hamper extensive application of these techniques in the clinical setting...
Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention GroupA Decensi
FIRC Chemoprovention Unit, European Institute of Oncology, Milan, Italy
Br J Cancer 78:572-8. 1998..Whereas a trial of tamoxifen in women already on transdermal HRT is warranted, prescription of HRT during tamoxifen may attenuate its activity...
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?P Boyle
European Institute of Oncology, Milan, Italy
Ann Oncol 14:1312-25. 2003..A programme of activities and research, focussing on three major themes [prevention (particularly tobacco control), screening, and education and training], was developed together with the European Code Against Cancer...
Long-term oncological results of breast conservative treatment with oncoplastic surgeryM Rietjens
Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy
Breast 16:387-95. 2007..53%). Patients with tumours larger than 2 cm were at greater risk of local recurrences and distant metastasis. Long-term oncologic results of BCT with oncoplastic surgery are comparable with the results of BCT randomized trials...
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lungG Pelosi
Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan School of Medicine, Milan, Italy
Am J Surg Pathol 25:363-72. 2001..Our findings suggest that TTF-1 could be involved in the development of small pulmonary adenocarcinomas, but it has not prognostic implications in patients with stage I NSCLC...
Genomic characterization of asymptomatic CT-detected lung cancersE Belloni
Department of Experimental Oncology, European Institute of Oncology, Milan, Italy
Oncogene 30:1117-26. 2011....
Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysisS Iodice
European Institute of Oncology, Milan, Italy
J Thromb Haemost 6:781-8. 2008..Despite a recognized association between venous thromboembolic events (VTE) and cancer, little is known about the strength and the features of this association. We performed a meta-analysis in order to clarify this issue...
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapyU Veronesi
Division of Senology, European Institute of Oncology, Via G Ripamonti 435, 20141 Milan, Italy
Ann Oncol 16:383-8. 2005..The aim of the study was to assess the role of axillary radiotherapy (RT) in reducing axillary metastases in patients with early breast cancer who did not receive axillary dissection...
Is colonoscopy a suitable investigation in the preoperative staging of ovarian cancer patients?D Ravizza
European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy
Dig Liver Dis 37:57-61. 2005..During ovarian cancer surgery, colorectal resection may be required. In our institution, preoperative colonoscopy is performed in order to assess visceral involvement...
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effectsM Colleoni
Division of Medical Oncology, University of Milan School of Medicine, European Institute of Oncology, Milan, Italy
Ann Oncol 17:232-8. 2006..We previously demonstrated efficacy and impact on serum vascular endothelial growth factor (VEGF) for metronomic cyclophosphamide (C) and methotrexate (M) in patients with breast cancer. New metronomic schedules were investigated...
Cancer control in women. Update 2003P Boyle
Dept of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Int J Gynaecol Obstet 83:179-202. 2003..Although more work is needed, it is becoming clear that there could be an important role of HPV testing to further enhance cervix cancer screening...
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4)P Bertuccio
Department of Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Ann Oncol 22:1420-6. 2011..Cigarette smoking is the best-characterized risk factor for pancreatic cancer. However, data are limited for other tobacco smoking products and smokeless tobacco...
Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention TrialD Serrano
Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
Pharmacogenomics J 11:100-7. 2011..Conversely, the CYP2D6*2A allele may be associated with increased efficacy of tamoxifen. These findings support the relevance of pharmaco-genomics in tailoring tamoxifen treatment...
Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002E Botteri
Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Ecancermedicalscience 3:149. 2009..The purpose of this paper is to describe the development of the TR at the European Institute of Oncology (IEO), Milan, Italy, from its origin to its current applications...
Cigarette smoking accelerates progression of alcoholic chronic pancreatitisP Maisonneuve
Epidemiology Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Gut 54:510-4. 2005..Smoking is a recognised risk factor for pancreatic cancer and has been associated with chronic pancreatitis and also with type II diabetes...
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesM Colleoni
Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy
Ann Oncol 15:1633-9. 2004..While data exist to clearly correlate small tumor size to better prognosis, the fact that very small breast cancers may express biological markers of dire prognosis leads many to ignore small tumor size during treatment decision-making...
Carcinoma of the vulvaU Beller
FIGO Annual Report Editorial Office, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Int J Gynaecol Obstet 83:7-26. 2003
Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measuresA Cortelezzia
Department of Hematology, IRCCS Maggiore Hospital and University of Milan, Milan, Italy
Leuk Lymphoma 44:1495-501. 2003..0001). There were fewer thrombotic events in the patients receiving i.v. LMWH prophylaxis than in those receiving i.v. UFH. The use of anticoagulants was safe and not associated with hemorrhages...
European Code Against Cancer and scientific justification: third version (2003)P Boyle
Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Ann Oncol 14:973-1005. 2003
Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological CancerM A Quinn
Int J Gynaecol Obstet 95:S43-103. 2006
Rationale for a study adding tamoxifen to HRTN Rotmensz
European Institute of Oncology, Milan, Italy
Eur J Cancer 38:S22-3. 2002
Epidemiology of pancreatic diseases in Lüneburg County. A study in a defined german populationP G Lankisch
Department of Internal Medicine, Municipal Clinic of Luneburg, Germany
Pancreatology 2:469-77. 2002..Worldwide, the incidence of pancreatic cancer is very well known, that of acute pancreatitis and chronic pancreatitis not. Our study sought to determine the incidence of all three pancreatic diseases in a well-defined population in Germany...
Tamoxifen for breast cancer among hysterectomised womenU Veronesi
Divisions of Senology, European Institute of Oncology, Milan, Italy
Lancet 359:1122-4. 2002..So far, no woman has died from breast cancer in this study. Decisions about introduction of tamoxifen to reduce risk of breast cancer remain important and open questions...
Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort studyJ V Parle
Division of Primary Care, Public and Occupational Health, Birmingham, UK
Lancet 358:861-5. 2001..2). INTERPRETATION: A single measurement of low serum thyrotropin in individuals aged 60 years or older is associated with increased mortality from all causes, and in particular mortality due to circulatory and cardiovascular diseases...
Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological CancerA P M Heintz
Int J Gynaecol Obstet 95:S161-92. 2006
Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infectionsJosiane Pillonel
Institut de Veille Sanitaire, Departement des Maladies Infectieuses, Saint Maurice, France
Transfusion 48:1567-75. 2008..The characteristics of recently infected donors, estimates of HIV-1 incidence, and the residual risk of transfusion-transmitted HIV-1 are presented, in both first-time and repeat donors...
Evolution of lung nodules < or =5 mm detected with low-dose CT in asymptomatic smokersM Bellomi
School of Medicine, University of Milano, 7 Via Festa del Perdono, 20122 Milan, Italy
Br J Radiol 80:708-12. 2007..7% did not change, 2.5% grew to > 5 mm and were followed yearly In conclusion, prevalent and incident nodules < or =5 mm detected by low-dose CT screening for lung cancer can be safely checked at 1 year intervals...
Gestational trophoblastic neoplasia. FIGO 6th Annual Report on the Results of Treatment in Gynecological CancerH Y S Ngan
Int J Gynaecol Obstet 95:S193-203. 2006
Carcinoma of the vagina. FIGO 6th Annual Report on the Results of Treatment in Gynecological CancerU Beller
Int J Gynaecol Obstet 95:S29-42. 2006
Carcinoma of the vulva. FIGO 6th Annual Report on the Results of Treatment in Gynecological CancerU Beller
Int J Gynaecol Obstet 95:S7-27. 2006
Carcinoma of the fallopian tube. FIGO 6th Annual Report on the Results of Treatment in Gynecological CancerA P M Heintz
Int J Gynaecol Obstet 95:S145-60. 2006
Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological CancerW T Creasman
Int J Gynaecol Obstet 95:S105-43. 2006
Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinomaG Puppa
Division of Pathology, CRO National Cancer Institute, Aviano, Italy
Br J Cancer 96:1118-26. 2007..Our findings suggest that fascin is a useful prognostic marker for colonic adenocarcinomas...
Risk of pancreatic cancer in patients with cystic fibrosisP Maisonneuve
Gut 56:1327-8. 2007
Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young ageP Lankisch
Department of Pediatric Oncology, University Hospital Dusseldorf, Dusseldorf, Germany
Pediatr Blood Cancer 46:767-72. 2006..The aim of the study was to evaluate whether serum cystatin C (CysC) may have a diagnostic impact on pediatric patients...
Has blood glucose level measured on admission to hospital in a patient with acute pancreatitis any prognostic value?P G Lankisch
Department of Internal Medicine, Municipal Clinic of Luneburg
Pancreatology 1:224-9. 2001..Early detection of pancreatic necrosis allows better management of the disease. Contrast-enhanced computed tomography (CT) as the gold standard for detecting pancreatic necrosis is expensive...
Cancer risk before and following organ transplantationP Maisonneuve
Br J Cancer 91:811; author reply 812. 2004
Prognostic implications of NUMB immunoreactivity in salivary gland carcinomasE Maiorano
Department of Pathological Anatomy, University of Bari, Italy
Int J Immunopathol Pharmacol 20:779-89. 2007..These data suggest that loss of Numb is implicated in aberrant differentiation programs of salivary gland carcinomas and may serve as a prognostic indicator in patients treated for these neoplasms...
